Karyopharm Therapeutics Inc. (KPTI) Financials
KPTI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 204.5 million | 373.4 million |
| 2023-12-31 | 240.4 million | 376.6 million |
| 2023-09-30 | 270.0 million | 370.4 million |
| 2023-06-30 | 297.8 million | 369.1 million |
KPTI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -43.9 million | 5.0 million |
| 2023-12-31 | -18.6 million | 5.2 million |
| 2023-09-30 | -29.5 million | 5.1 million |
| 2023-06-30 | -25.7 million | 6.1 million |
KPTI Net Income
No data available :(
KPTI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 149.0 million | - | 5.3 million |
| 2023-12-31 | 192.1 million | - | 6.1 million |
| 2023-09-30 | 208.3 million | - | 6.9 million |
| 2023-06-30 | 236.8 million | - | 7.6 million |
KPTI Shares Outstanding
KPTI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 195000 | 35.3 million | 29.5 million | - |
| 2023-12-31 | - | 39.3 million | 30.7 million | - |
| 2023-09-30 | - | 35.6 million | 30.8 million | - |
| 2023-06-30 | - | 31.5 million | 34.5 million | - |
KPTI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 33.1 million | 2.0 million |
| 2023-12-31 | 33.7 million | 1.6 million |
| 2023-09-30 | 36.0 million | 911000 |
| 2023-06-30 | 37.6 million | 1.2 million |
KPTI
Price: $0.98
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -0.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -30.9 millionMarket Capitalization: 133.6 million